Short-term course of the neuropsychological profile in myotonic dystrophy type 1: a 12-month longitudinal study

Myotonic dystrophy type 1 (DM1) is a complex, multisystemic neuromuscular disorder that affects various systems, including the muscular and central nervous systems. The natural history of DM1 includes a cognitive decline over time across multiple cognitive functions. However, the course of the cognitive profile remains unknown over short follow-up intervals. The study aimed to document the course of the neuropsychological profile in adults with DM1 over 12 months using classic paper-pencil tests and computerized cognitive tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB®). Adult participants with a genetically confirmed diagnosis of juvenile, adult, or late-onset phenotype of myotonic dystrophy type 1 (DM1) underwent a battery of traditional paper-and-pencil tests alongside four assessments from the computerized cognitive battery, CANTAB®. Cognitive functions were evaluated at baseline and at two follow-up points, each 6 months apart. Repeated measures ANOVAs were conducted, followed by post hoc analyses to compare results across the different time points. Significant changes were interpreted in relation to the measurement error. Forty-four participants with DM1 (m = 45.5 ± 11.2 years) were assessed (50% juvenile, 38.6% adult, 11.4% late-onset). Results showed an overall stability in cognitive functions at both 6 and 12 months. However, verbal memory (California Verbal Learning Test) and multitasking skills (CANTAB®) exhibited an improvement outside of the measurement error, likely reflecting a learning effect. Short-term progression studies are essential to improve trial readiness by documenting the best outcome measures to assess treatment effectiveness and gathering a comprehensive overview of the cognitive profile progression in DM1.

Authors

Institutions

Publication Details

Journal
BMC Neurology
Published
2026-04-28
DOI
https://doi.org/10.1186/s12883-026-04816-6
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Short-term course of the neuropsychological profile in myotonic dystrophy type 1: a 12-month longitudinal study

Benjamin Gallais, J Fortin, Isabelle Gaudet, Cynthia Gagnon et al.
BMC Neurology
Genetic Neurodegenerative Diseases
article

Short-term course of the neuropsychological profile in myotonic dystrophy type 1: a 12-month longitudinal study

Benjamin Gallais, J Fortin, Isabelle Gaudet, Cynthia Gagnon, Isabelle Côté
article en

Abstract

Myotonic dystrophy type 1 (DM1) is a complex, multisystemic neuromuscular disorder that affects various systems, including the muscular and central nervous systems. The natural history of DM1 includes a cognitive decline over time across multiple cognitive functions. However, the course of the cognitive profile remains unknown over short follow-up intervals. The study aimed to document the course of the neuropsychological profile in adults with DM1 over 12 months using classic paper-pencil tests and computerized cognitive tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB®). Adult participants with a genetically confirmed diagnosis of juvenile, adult, or late-onset phenotype of myotonic dystrophy type 1 (DM1) underwent a battery of traditional paper-and-pencil tests alongside four assessments from the computerized cognitive battery, CANTAB®. Cognitive functions were evaluated at baseline and at two follow-up points, each 6 months apart. Repeated measures ANOVAs were conducted, followed by post hoc analyses to compare results across the different time points. Significant changes were interpreted in relation to the measurement error. Forty-four participants with DM1 (m = 45.5 ± 11.2 years) were assessed (50% juvenile, 38.6% adult, 11.4% late-onset). Results showed an overall stability in cognitive functions at both 6 and 12 months. However, verbal memory (California Verbal Learning Test) and multitasking skills (CANTAB®) exhibited an improvement outside of the measurement error, likely reflecting a learning effect. Short-term progression studies are essential to improve trial readiness by documenting the best outcome measures to assess treatment effectiveness and gathering a comprehensive overview of the cognitive profile progression in DM1.

BMC Neurology
Université du Québec à Chicoutimi (CA), Université de Sherbrooke (CA), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean (CA)
Myotonic Dystrophy Foundation, Fonds de recherche du Québec
Quality Education
Openalex Percentile: Top 7%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.